NCT05524649 (BABYCARE) is a NA clinical trial of Food Supplement 1 in Microbial Colonization, sponsored by AB Biotics, SA.

Who is sponsoring NCT05524649?

NCT05524649 is sponsored by AB Biotics, SA.

What drugs are being tested in NCT05524649?

Interventions in NCT05524649: Food Supplement 1, Food Supplement 2, Placebo.

What condition does NCT05524649 study?

NCT05524649 studies Microbial Colonization.

Is NCT05524649 still recruiting?

NCT05524649 is currently recruiting now. Last updated 11 February 2025.

Last reviewed 2025-02-11 · How we verify

NCT05524649: BABYCARE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Probiotics on Infant's Fecal Microbiota Composition

Recruiting now NA Last updated 11 February 2025

What this trial tests

NA trial testing Food Supplement 1 in Microbial Colonization in 120 participants. Currently enrolling.

Timeline

1 June 2022

Primary endpoint
31 August 2025

31 December 2025

Quick facts

Lead sponsor	AB Biotics, SA
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	120
Start date	1 June 2022
Primary completion	31 August 2025
Estimated completion	31 December 2025
Sites	2 locations across Spain, Mexico

Drugs / interventions tested

Food Supplement 1
Food Supplement 2
Placebo

Conditions studied

Microbial Colonization — all drugs for Microbial Colonization →

Sponsor

AB Biotics, SA — full company profile →

Who can join

Adults 1 Day to 90 Days, any sex, with Microbial Colonization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized clinical trial to evaluate the effect of two probiotic strains which belong to Bifidobacterium Longum and Pediococcus pentosaceus species on fecal microbiota composition in healthy infants. Secondary outcomes comprise evaluation of anthropometric growth, digestive tolerance, sleeping habits, incidence of functional gastrointestinal disorders, incidence of gastrointestinal and respiratory infections, allergic reactions and safety and tolerability of the product.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Microbial Colonization

Currently open trials in the same condition.

NCT06970262 — FMT for Lung and Associated-organ Rescue Efficacy in ARDS Patients · NA · recruiting
NCT06805994 — Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment · Phase 1 · recruiting
NCT06938386 — Pilot Haskap Metabolite Timing Project · NA · active not recruiting
NCT06920641 — Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults · NA · recruiting
NCT06541808 — Balance, Autonomic Response, and Sensory Modulation to Dosage of Mechanical Vagal Stimulation in Healthy Adults · NA · recruiting

Other AB Biotics, SA trials

Trials by the same sponsor.

NCT07193927 — Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Diseas · Phase 2 · not yet recruiting
NCT06604234 — Impact of a Probiotic Combination on Quality of Life and Symptoms in Peri- and Postmenopausal Women · NA · completed
NCT06193096 — Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners · NA · completed
NCT05688397 — Evaluation of the Vaginal Colonization of Two New Lactobacillus Strains After Oral Administration in Healthy Volunteers · NA · completed
NCT05279534 — Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05524649 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AB Biotics, SA
Last refreshed: 11 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05524649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing